Presentation TCT 2012 LEADERS 5-Year: A Prospective, Randomized Trial of Bioabsorbable Polymer-based Biolimus-Eluting vs. Sirolimus-Eluting Stents Presenter: Patrick Serruys October 25, 2012
Presentation TCT 2012 Continuity Equation: Streamlining Processes from Pre-Market Approval to Post-Market Surveillance Presenter: Roxana Mehran October 25, 2012
Presentation TCT 2012 What Is Optimal Medical Management for Carotid Disease, and What Residual Risk Remains Without Revascularization? Presenter: Michael Jaff October 22, 2012
Presentation TCT 2012 Are CEA Outcomes Continuing to Improve? Evolution of a 60-Year-Old Procedure Presenter: Takao Ohki October 22, 2012
Presentation TCT 2012 Branch or Embolize? Managing Iliac Aneurysms Involving the Hypogastrics Presenter: James McKinsey October 22, 2012
Presentation TCT 2012 Final Results from the Lombard Pythagoras Study for Angled Neck Abdominal Aneurysms Presenter: William Gray October 22, 2012
Presentation TCT 2012 Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con! Presenter: Lawrence Garcia October 22, 2012
Presentation TCT 2012 Tips and Tricks for Successful Crossing of Femoropopliteal CTOs Presenter: Andrej Schmidt October 23, 2012
Presentation TCT 2012 Femoral Access Site Complications: Diagnostic and Therapeutic Tips and Tricks Presenter: Stephen Ramee October 23, 2012